Stocks · Korea
175250
KOSDAQ
Icure Pharmaceutical In
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+0.78%
1M-20.28%
3M-41.39%
6M-41.39%
1Y-41.39%
YTD-41.39%
52W high3,300원
52W low1,515원
From 52W high-49.03%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 594억 | -268억 | -425억 | -45.1% |
| 2023 | 568억 | -227억 | -323억 | -39.9% |
| 2024 | 692억 | -172억 | 24,731,710원 | -24.8% |
| 2025 | 834억 | -120억 | -345억 | -14.3% |
| Quarterly | ||||
| 2024 4Q | 207억 | -46억 | -162억 | -22.4% |
| 2025 1Q | 221억 | -24억 | -25억 | -11.0% |
| 2025 2Q | 253억 | -44억 | -98억 | -17.5% |
| 2025 3Q | 251억 | -33억 | -39억 | -12.9% |
| 2025 4Q | 109억 | -18억 | -184억 | -17.0% |
| 2026 1Q | 322억 | 2억 | -7억 | 0.6% |
Company
Address: 서울특별시 강남구 봉은사로104길 10 7층
Recent filings
- 2026-09-18[기재정정]반기보고서 (2026.06)
- 2026-09-03[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-28[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-28[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-18[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-14반기보고서 (2026.06)
- 2026-08-14[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-12[기재정정]주요사항보고서(유상증자결정) Major
- 2026-08-05[기재정정]주요사항보고서(유상증자결정) Major
- 2026-06-29주요사항보고서(유상증자결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.